Immunovant, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2018 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Immunovant, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2018 to Q2 2025.
- Immunovant, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$121M, a 38.4% decline year-over-year.
- Immunovant, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$447M, a 64.1% decline year-over-year.
- Immunovant, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$414M, a 59.6% decline from 2023.
- Immunovant, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$259M, a 22.9% decline from 2022.
- Immunovant, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$211M, a 34.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)